RTW BIOTECH OPPORTUNITIES LTD
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1 | Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a) | Name | GPML ATO Horizon Choice Pension Plan Re P Le Page
| ||||
| 2 | Reason for the notification
| |||||
| a) | Position/status
| PCA of Mr P Le Page, Director of RTW Biotech Opportunities Ltd | ||||
| b)
| Initial notification /Amendment | Initial notification
| ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a) | Name | RTW Biotech Opportunities Ltd | ||||
| b) | LEI | 549300Q7EXQQH6KF7Z84
| ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary shares of no par value
GG00BKTRRM22 | ||||
| b) | Nature of the transaction | Purchase of Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price |
50,000
$1.14
| ||||
| e) | Date of the transaction | 10 April 2025
| ||||
| f) | Place of the transaction | London Stock Exchange
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.